JANX - Janux Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.25
DETAILS
HIGH:
$55.00
LOW:
$14.00
MEDIAN:
$24.50
CONSENSUS:
$28.25
UPSIDE:
56.68%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: JANX has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.